Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study.

A Advani; B Coiffier; MS Czuczman; M Dreyling; J Foran; E Gine; C Gisselbrecht; N Ketterer; S Nasta; A Rohatiner; IG Schmidt-Wolf; M Schuler; J Sierra; MR Smith; G Verhoef; JN Winter; J Boni; E Vandendries; M Shapiro; L Fayad

doi:10.1200/JCO.2009.25.1900

Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study.

A Advani, B Coiffier, MS Czuczman, M Dreyling, J Foran, E Gine, C Gisselbrecht, N Ketterer, S Nasta, A Rohatiner, IG Schmidt-Wolf, M Schuler, J Sierra, MR Smith, G Verhoef, JN Winter, J Boni, E Vandendries, M Shapiro, L Fayad

Department of Medicine

Research output: Contribution to journal › Article › Research

266 Citations (Scopus)

Original language	English
Pages (from-to)	2085-2093
Journal	J Clin Oncol
Volume	28
Issue number	12
DOIs	https://doi.org/10.1200/JCO.2009.25.1900
Publication status	Published - 1 Jan 2010

Access to Document

10.1200/JCO.2009.25.1900

Cite this

Advani, A., Coiffier, B., Czuczman, MS., Dreyling, M., Foran, J., Gine, E., Gisselbrecht, C., Ketterer, N., Nasta, S., Rohatiner, A., Schmidt-Wolf, IG., Schuler, M., Sierra, J., Smith, MR., Verhoef, G., Winter, JN., Boni, J., Vandendries, E., Shapiro, M., & Fayad, L. (2010). Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study. J Clin Oncol, 28(12), 2085-2093. https://doi.org/10.1200/JCO.2009.25.1900

@article{0ef16795c76144019078f94c96265054,

title = "Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study.",

author = "A Advani and B Coiffier and MS Czuczman and M Dreyling and J Foran and E Gine and C Gisselbrecht and N Ketterer and S Nasta and A Rohatiner and IG Schmidt-Wolf and M Schuler and J Sierra and MR Smith and G Verhoef and JN Winter and J Boni and E Vandendries and M Shapiro and L Fayad",

year = "2010",

month = jan,

day = "1",

doi = "10.1200/JCO.2009.25.1900",

language = "English",

volume = "28",

pages = "2085--2093",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "12",

}

Advani, A, Coiffier, B, Czuczman, MS, Dreyling, M, Foran, J, Gine, E, Gisselbrecht, C, Ketterer, N, Nasta, S, Rohatiner, A, Schmidt-Wolf, IG, Schuler, M, Sierra, J, Smith, MR, Verhoef, G, Winter, JN, Boni, J, Vandendries, E, Shapiro, M & Fayad, L 2010, 'Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study.', J Clin Oncol, vol. 28, no. 12, pp. 2085-2093. https://doi.org/10.1200/JCO.2009.25.1900

TY - JOUR

T1 - Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study.

AU - Advani, A

AU - Coiffier, B

AU - Czuczman, MS

AU - Dreyling, M

AU - Foran, J

AU - Gine, E

AU - Gisselbrecht, C

AU - Ketterer, N

AU - Nasta, S

AU - Rohatiner, A

AU - Schmidt-Wolf, IG

AU - Schuler, M

AU - Sierra, J

AU - Smith, MR

AU - Verhoef, G

AU - Winter, JN

AU - Boni, J

AU - Vandendries, E

AU - Shapiro, M

AU - Fayad, L

PY - 2010/1/1

Y1 - 2010/1/1

U2 - 10.1200/JCO.2009.25.1900

DO - 10.1200/JCO.2009.25.1900

M3 - Article

SN - 0732-183X

VL - 28

SP - 2085

EP - 2093

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 12

ER -